Liver tissue engineering with hepatic stem cells provides a promising alternative to liver transplantation in patients with acute and chronic hepatic failure. In this study, a three-dimensional (3D) bioscaffold was introduced for differentiation of rat bone marrow mesenchymal stem cells (BMSCs) into hepatocytes. For hepatocyte differentiation, third passage BMSCs isolated from normal adult F344 rats were seeded into collagen-coated poly(lactic-co -glycolic acid) (C-PLGA) 3D scaffolds with hepatocyte differentiation medium for 3 weeks. Hepatogenesis in scaffolds was characterized by reverse transcript PCR, western blot, confocal laser scanning microscopy (CLSM), periodic acid-Schiff staining, histochemistry, and biochemical assays with hepatic-specifi c genes and markers. A monolayer culture system was used as a control differentiation group. The results showed that isolated cells possessed the basic features of BMSCs. Differentiated hepatocyte-like cells in C-PLGA scaffolds expressed hepatocyte-specifi c markers [eg, albumin (ALB), α-fetoprotein, cytokeratin 18, hepatocyte nuclear factor 4α, and cytochrome P450] at mRNA and protein levels. Most markers were expressed in C-PLGA group 1 week earlier than in the control group. Results of biocompatibility indicated that the differentiated hepatocyte-like cells grew more stably in C-PLGA scaffolds than that in controls during a 3-week differentiation period. The signifi cantly higher metabolic functions in hepatocyte-like cells in the C-PLGA scaffold group further demonstrated the important role of the scaffold. Conclusion: As the phenomenon of transdifferentiation is uncommon, our successful transdifferentiation rates of BMSCs to mature hepatocytes prove the superiority of the C-PLGA scaffold in providing a suitable environment for such a differentiation. This material can possibly be used as a bioscaffold for liver tissue engineering in future clinical therapeutic applications.
Introduction
E nd-stage liver failure is a devastating disorder with multiple etiologies and currently the only effective treatment is liver transplantation [ 1 , 2 ] . Owing to the shortage of suitable liver grafts, a great number of patients will die while waiting for liver transplantation [ 3 ] . Research from our laboratory and others have previously focused on the development of a hepatocyte-based extracorporeal liver support system [4] [5] [6] [7] . One of the limiting factors for such a system is the availability of viable and functional hepatocytes [ 8 , 9 ] . Liver tissue engineering provides a promising alternative to liver transplantation in patients with acute hepatic failure (AHF) and end-stage chronic liver disease [10] [11] [12] [13] .
Numerous studies using liver tissue engineering for treatment of end-stage liver disease demonstrated survival of hepatocytes transplanted heterotopically, improvement in survival of transplanted hepatocytes with hepatotrophic stimulation, and enhancement in proliferation [14] [15] [16] [17] . However, the main challenge has been the limited number of viable and functional cells after implantation because of mature hepatocytes almost losing their differentiation and proliferation capabilities, and poor oxygen and nutrient supply during the initial period after transplantation due to the poor microenvironment for implanted cells [ 18 ] .
To address these issues, many researchers attempted to establish three-dimensional (3D) tissues with biomimetic
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Collagen-coated PLGA scaffold preparation
Collagen-coated porous scaffolds were prepared from poly(lactic-co -glycolic acid) (PLGA molar ratio of 85:15; Sigma Chemical Corporation., St. Louis, MO) and type I collagen from rat tail (Gibco BRL, Grand Island, NY) by our previously described method [ 28 ] . In brief, PLGA (3 wt%) was dissolved in DMSO and frozen at −20°C. The frozen polymer solution was immersed in a precooled 30 wt% ethanol aqueous solution, and the solvent DMSO was extracted and replaced with the ethanol solution, a nonsolvent for PLGA. Subsequently, the ethanol was removed by drying at room temperature and PLGA porous scaffolds were obtained. A foam-like collagen solution was introduced into the PLGA scaffolds and freeze-dried at −20°C to form a porous sponge. To control the pore size of PLGA scaffolds within a resultant range of 150-350 μm diameter, 2-step coarsening was used. In brief, after coarsening at 25°C for 5 h, the system was cooled down to 20°C and coarsened again for another 2.5 h. The solvents were then solidifi ed at −20°C for 2 h, and were removed by freeze-drying. For cell culture and transplantation experiments, the scaffolds were cut into discs of 10 mm diameter and 3 mm thickness. C-PLGA scaffolds were sterilized overnight in 70% ethanol and washed 3 times in phosphate-buffered saline (PBS) before cell culture. For characterization of their inner microstructure with scanning electron microscopy (SEM, JEOL JEM-200CX, Japan), the 3D C-PLGA scaffolds were fractured in liquid nitrogen. The diameter of the pores was measured and averaged from the SEM images by a graph calculator software, SMILE view [ 31 ] .
Rat bone marrow mesenchymal stem cells isolation
Bone marrow cells were harvested by fl ushing the diaphysis of femurs and tibias from Fischer 344 rats with PBS containing 1% BSA, 100 U/mL penicillin and 100 μg/mL streptomycin. Following washing and resuspending in 5 mL PBS, the cells were carefully laid on 5 mL Ficoll-Paque (GE Healthcare, Uppsala, Sweden). After centrifugation at 400 g at room temperature for 30 min, the cells were harvested from the plasma-Ficoll interface and washed 3 times with PBS and maintained at 4°C for further use [ 24 ] . BMSCs were allowed to attach in DMEM medium supplemented with 10% FBS overnight at 37°C. Floating cells were washed out on the second day. All remaining cells were maintained in fresh DMEM supplemented with 10% FBS culture medium. The animals received humane care according to the guidelines prepared by the National Institute of Health, USA.
Surface marker characterized by fl ow cytometry
For characterization of BMSCs by fl ow cytometry, the fi rst, fourth, and seventh passage BMSCs with 1 × 10 6 cells were incubated with direct PE-or FITC-conjugated mouse antirat monoclonal antibodies recognizing CD29 (ABR Affi nity materials and replace mature hepatocytes with stem cells [ 10 , 19-21 ] . Recent evidence indicated that cells forming the tissue to be regenerated are necessary for effi cient tissue regeneration and stem cells are promising in both proliferation activity and differentiation potential [ 22 , 23 ] . Bone marrow mesenchymal stem cells (BMSCs) possess great potential for liver tissue engineering because autologous BMSCs can be isolated easily, proliferated extensively in vitro, and transdifferentiated into hepatocyte-like cells for transplantation [ 22 ] . We have previously isolated, from adult rat's bone marrow, a subset of stem cells that can be differentiated into hepatocyte-like cells in vitro with expression of hepatocyte-specifi c genes and proteins [ 24 ] . More importantly, these cells were able to metabolize urea and synthesize ALB in vitro. Recently, it was shown that a population of cells in the bone marrow expressing mesenchymal stem cell antigens could differentiate in vitro into hepatocytelike cells, which exhibit highly differentiated hepatocyte functions [ 22 ] . We also showed that AHF in rats can alter or "prime" the bone marrow to increase the number of hepatic progenitor cells.
Other recent studies also have demonstrated that bone marrow-derived hepatic stem cells may play a major role in liver regeneration following acute or chronic hepatic failure. Differentiation of BMSCs into hepatocytes in monolayer or two-dimensional (2D) culture systems is now well established [25] [26] [27] , but challenges still need to be overcome to develop functional hepatocytes suitable for implantation from BMSCs.
Our recent study demonstrated that collagen-modifi ed PLGA (C-PLGA) scaffolds are superior to the 2D culture system in supporting growth and proliferation of primary human hepatocytes, and selected hepatic metabolism functions including ALB secretion, urea synthesis, and ammonia clearance [ 28 ] . Many other studies confi rmed that 3D scaffolds can signifi cantly improve differentiation of embryonic stem cells into hepatocytes and provide an environment for liver regeneration-induced hepatocyte-like cells [ 21 , 29 , 30 ] .
To demonstrate our hypothesis that BMSC can be differentiated into hepatocyte-like cells within designed C-PLGA scaffolds, with improved viability and hepatocyte-specifi c functions, we used in this study a combination of methods. RT-PCR, western blot, confocal laser scanning microscopy (CLSM), periodic acid-Schiff (PAS) staining, histochemistry, and biochemical assays with hepatic-specifi c genes and markers were all performed to show the ability and importance of 3D bioscaffolds to support differentiation.
Materials and Methods
Chemicals and reagents
Chemicals for cell isolation and culture were purchased from Sigma Chemical Corporation (St. Louis, MO). Dulbecco's modifi ed Eagle's medium (DMEM), Iscove's modifi ed Dulbecco's medium (IMDM), rat tail collagen I, antibiotic-antimycotic, trypsin-ethylenediaminetetraacetic acid (EDTA), and fetal bovine serum (FBS) were purchased from Invitrogen Corporation (Carlsbad, CA). Bovine serum albumin (BSA), MTT assay kit, dimethylsulfoxide (DMSO), ITX mixture, and oncostatin (OSM) were from Sigma Chemical Corporation (St. Louis, MO). Hepatocyte growth factor (HGF) was from Cell Science (Canton, MA), regular
RT-PCR
Total RNA was extracted from undifferentiated rat BMSCs, various stages of the differentiated hepatocytes cultured in scaffolds and culture fl asks as well as primary hepatocytes using TRIZOL (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Total RNA was reverse-transcribed and cDNA was synthesized using Quantitect reverse transcription reagent (Qiagen, Valencia, CA). In brief, the purifi ed 1.0 μg RNA was incubated in gDNA wipeout buffer at 42°C for 2 min to remove contaminating genomic DNA and the RNA sample was then transcribed at 42°C for 15 min. The reverse-transcribed cDNA was subsequently inactivated at 95°C for 3 min and amplifi ed by PCR using rat liver-specifi c gene primers (Invitrogen, Carlsbad, CA) as listed in Table 1 . RT-PCR was performed as described previously [ 28 ] .
Western blot
The cultured cells were lysed by a lysis buffer (Pierce, Rockford, IL) containing protease inhibitor and EDTA. Protein concentration in cell lysates was measured using the Coomassie Plus-The Better Bradford™ Assay Kit (Pierce, Rockford, IL). About 20 μg of total protein was subjected to 4%-12% Bis-Tris gel electrophoresis and transferred to nitrocellulose membranes. Blots were blocked with 5% nonfat milk in Tris-buffered saline containing Tween-20. Blot membranes were incubated with anti-rat primary antibodies of liver functional markers including ALB, cytochrome P450 (P450), cytokeratin 18 (CK18), and cytokeratin (CK19) at 4°C overnight (fi nal concentration of different antibodies according to the manufacturer's recommendations). Membranes were then washed, and specifi cally bound immunoglobulins were detected by incubation with horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. Protein bands were visualized by enhanced chemiluminescence systems (Pierce) and the images were captured on medical X-ray fi lm (Phoenix Research, Hayward, CA).
BioReagents, CO), CD45 (Invitrogen, Carlsbad, CA), CD90, and β-2 microglobulin (β 2 m, Santa Cruz Biotechnology, Santa Cruz, CA) for 20 min in the dark at room temperature, followed by washing and resuspending in PBS. The immunoglobulin isotype incubation was used as a negative control. FACS analysis was performed with a FACSCalibur system (Beckman Coulter FC500).
Hepatocyte differentiation with C-PLGA scaffolds
The BMSCs seeding in scaffolds was performed as previously described [ 28 ] . C-PLGA scaffolds were placed and immobilized by injection needles in 24-well culture plates. The third passage BMSCs with 1 × 10 6 cells (BMSCs suspension 5 × 10 6 cells/mL) were directly dropped onto the surface of the each scaffold. While agitating the plate, vacuum was applied for 5 min and then the pressure returned to ambient. Additional vacuum/aeration cycles were performed until the scaffold absorbed no further cells suspension. The scaffold was then removed to a new well with 2 mL serum-free hepatocyte differentiation medium (IMDM supplemented with 20 ng/mL hHGF, 100 μM dexamethasone, 50 mg/mL ITX + premix, 100 U/mL penicillin, and 100 μg/mL streptomycin) and maintained in the same culture medium for an initial 2 weeks. Thereafter, the cells were changed into a maturation medium (IMDM supplemented with 20 ng/mL OSM, 100 μM dexamethasone, 50 mg/mL ITX + premix, 100 U/mL penicillin, and 100 μg/mL streptomycin) and maintained for an additional week. As a control monolayer culture system, BMSCs with 5 × 10 5 cells (BMSCs suspension 2 × 10 4 cells/cm 2 ) were differentiated in T-25 culture fl asks and cover slides in 24-well culture plates (cell concentration was same with in T-25 culture fl asks). The culture medium was replaced with fresh medium twice a week. Before and after differentiation at day 7, 14, and 21, the differentiated BMSCs were harvested and characterized for hepatic function with different approaches including RT-PCR, western blot, CLSM, PAS staining, histochemistry, and biochemistry. The experiment in hepatocyte differentiation with C-PLGA scaffolds was repeated >3 times.
T able 1. T he P rimers of L iver F unctional G ene
Gene NCBI access number Length Primer
Abbreviations: ALB, Albumin; AFP, α-fetoprotein; G6PD, glucose-6-phosphate dehydrogenase; CK18, cytokeratin 18; CK19, cytokeratin 19; HNF-4, hepatocyte nuclear factor 4; GAPDH, glyceraldehyde phosphate dehydrogenase.
cells from BMSCs in bioscaffolds, the culture supernatants were measured for ammonia concentration determined by an enzymatic l -glutamate dehydrogenase assay (SigmaAldrich, St. Louis, MO) and for urea concentration measured by a commercially available QuantiChrom™ urea assay kit (BioAssay Systems, Hayward, CA). Ammonia elimination and urea synthesis were assessed by incubating the hepatocytes with 1 mmol/L NH 4 Cl for 2 h at 37°C [ 28 ] . Diazepam concentration was measured at various stages of differentiation before (day 0) and after differentiation (at days 7, 14, and 21) by high performance liquid chromatography (HPLC) as previously described [ 28 ] . Each sample was tested in triplicate at the same time.
Histochemical and PAS staining
The morphology of differentiated hepatocyte-like cells in C-PLGA scaffolds was characterized by hematoxylin-eosin (H&E) staining. C-PLGA scaffolds containing differentiated cells were fi xed with 4% formaldehyde in PBS for 3 h at 4°C and then embedded in paraffi n, sectioned into longitudinal and horizontal cross sections (5 μm thickness). The specimens were stained with H&E and examined under a light microscope (Nikon E800). For glycogen detection, PAS staining was performed to determine glycogen expression in differentiated hepatocyte-like cells in C-PLGA scaffolds. Specimen slides fi xed with 4% paraformaldehyde were rinsed in slowly running tap water, and then immersed in periodic acid solution for 5 min at room temperature. After that, the specimen slides were rinsed in distilled water and immersed in Schiff's reagent for 15 min at room temperature. Followed by washing in running tap water for 5 min, slides were counterstained in hematoxylin solution for 90 s and rinsed in running tap water for 15-30 s, dried, and examined microscopically.
Statistical analysis
Data were evaluated by Student's t -test for each pair using software SPSS version 16.0. The level of signifi cance for all statistical analyses was P < 0.05.
Results
Scaffold properties
The morphology of the C-PLGA scaffold under SEM is shown in Figure 1 . C-PLGA scaffolds with round-shaped pores and an average pore diameter of 150-350 μm were successfully prepared. Their porosities were 94%. The images showed that pores possessed a highly interconnected network, which is important for cell infi ltration and nutrient transportation.
Phenotype characteristic of BMSCs
The results of phenotypic properties of BMSCs ( Fig. 2 ) showed that BMSCs were positive for CD29 (97.5%-98.1% within passage 1 to passage 7) and CD90 (93.8%-98.3% within passage 1 to passage 7), but negative for CD45 (0.4%-0.6% within passage 1 to passage 7) and β 2 m (0.3%-0.8% within passage 1 to passage 7). These data suggested that the cells used for differentiation in this study exhibited the characteristics of BMSCs.
Evaluation of cell survival and scaffold biocompatibility
To evaluate biocompatibility and effi ciency of C-PLGA scaffolds in BMSC differentiation into hepatocyte-like cells, we observed the survival of differentiated hepatocyte-like cells in scaffolds and in a monolayer culture system. The cells' survival was determined by Vybrant CFDA SE cell tracer kit (Invitrogen, Carlsbad, CA) during the period of differentiation. Each sample was tested in triplicate at the same time. Ten millimolar CFDA SE stock solution was prepared by dissolving 500 μg CFDA SE in 90 μL of DMSO. A 10 μM CFDA SE working solution was obtained by diluting in PBS. For labeling the differentiated BMSCs in PLGA scaffolds, the medium was removed and pre-warmed (37°C). CFDA SE working solution was added into the cultures, and then the cultures were incubated with 5% CO 2 at 37°C for 15 min. We replaced the loading solution with fresh, prewarmed (37°C) DMEM containing 10% FBS and incubated the cultures with 5% CO 2 at 37°C for 30 min. Subsequently, we washed with PBS several times and fi xed with 4% paraformaldehyde for 15 min at room temperature and rinsed with PBS. Sections were cut and mounted on glass slides with Xylene-Soluble Mounting Medium and covered with coverslips. Cells labeled with CFDA SE were visualized by CLSM (Olympus IX 70 + Fluoview 300), using standard fl uorescein wavelengths (fl uorescence excitation/emission maxima: 488/517 nm).
The density of cells attached in scaffolds was evaluated by using an MTT colorimetric assay. In brief, the third passage BMSCs were cultured in C-PLGA scaffolds (6 × 10 5 cells/scaffold) and monolayer culture system (5 × 10 5 cells/T-25 fl ask, 2 × 10 4 cells/cm 2 ). The scaffolds with differentiated cells were washed with PBS 3 times, transferred into a new 24-well plate containing 5:1 ratio of media and MTT solution (0.5%, Sigma, Germany 5 mg/mL in PBS), respectively, and incubated for 2 h at 37°C. After removing the culture media, 0.5 mL of extraction solution (DMSO) was added. The scaffolds were washed extensively by pipetting up and down repeatedly to allow total color release. The absorbance of the supernatant was read with a microplate reader with a 630-nm reference wavelength and 570 nm test wavelength. Cell number was determined through a standard curve that was established by using a known number of cells counted by a hemocytometer. The cells' density was analyzed once a week. Each sample was tested in triplicate at the same time. The cell growth curve was made with the time as abscissa ( x -coordinate) and the cells number as ordinate ( y -coordinate) [ 28 ] .
Biochemical assay for hepatocyte-enriched metabolic functions
For evaluation of hepatocyte-enriched metabolic functions, ALB secretion, urea synthesis, ammonia elimination, and diazepam clearance from BMSC-derived hepatocytelike cells in both of our differentiation systems were assayed. ALB secreted from BMSC-derived hepatocyte-like cells on C-PLGA scaffolds was tested by ELISA to evaluate hepatic function at various stages of differentiation (in weeks 0, 1, 2, and 3). The culture supernatant harvested from differentiated cells was tested using a commercially available kit. The assay was performed as described previously [ 28 ] . To evaluate the hepatic metabolic function of differentiated hepatocyte-like CK19 after 3 weeks of differentiation from both 2 different hepatocyte-like cells. Three proteins (ALB, P450, and CK18) were expressed in the fi rst week of differentiation in the scaffold group but absent in control. All 4 markers detected by western blot were expressed earlier by 1 week in the scaffold group than those in the control group. 
Cell survival and scaffold biocompatibility
Results of RT-PCR
The results of RT-PCR shown in Figure 3A indicated that after 3 weeks of differentiation, differentiated hepatocytelike cells were positive for several liver functional genes, including ALB, AFP, CK18, CK19, G6PD, and HNF-4, in both groups of C-PLGA scaffolds and control. All genes were expressed 1 week earlier in differentiated hepatocyte-like cells in C-PLGA scaffolds versus those in controls. ALB, AFP, CK18, and CK19, in particular, were expressed in the fi rst week of differentiation in the scaffold group. In contrast, these genes were expressed in the second week in monolayer culture group.
Results of western blot
Western blot results shown in Figure 3B indicated 
FIG. 2.
Immunophenotyping of rat bone marrow mesenchymal stem cells (BMSCs) using fl ow cytometry. Bone marrow mesenchymal stem cells (BMSCs) were positive for CD29 (97.5%-98.1%) and CD90 (93.8%-98.3%) within passage 1 to passage 7. These cells were negative for CD45 (0.4%-0.6%) and β 2 m (0.3%-0.8%) within passage 1 to passage 7. The results shown are representative of 3 independent experiments (P-1, passage 1; P-4, passage 4; P-7, passage 7).
and after differentiation in weeks 1, 2, and 3 was 90%, 85%, 60%, and 45%, respectively; data not shown) after 1 week of differentiation under phase-contrast microscopy ( Fig.  4E-4H ). Cell growth curves ( Fig. 5 ) revealed that the densities of differentiated hepatocyte-like cells were signifi cantly higher in the scaffold group compared with the control after 3 weeks of differentiation. Thus, the lifespan of hepatocytelike cells differentiated in 3D scaffolds was prolonged when compared with those in monolayer culture.
Biochemical assay for hepatic metabolism functions
The results of ALB detection ( Fig. 6A ) showed that ALB concentration was 0.04 ± 0.02 pg/cell/h in the fi rst week, increased to 0.14 ± 0.02 pg/cell/h in the second week, and rose to 0.58 ± 0.15 pg/cell/h in the third week in scaffold. In contrast, ALB was not detected in the monolayer culture group in the fi rst week. In the next 2 weeks, ALB was 0.07 ± 0.2 pg/cell/h and 0.36 ± 0.11 pg/cell/h, respectively. Compared with control group, ALB secreted from differentiated hepatocyte-like cells in the scaffold group was signifi cantly higher than that in control ( P < 0.05). Urea synthesis assay ( Fig. 6B ) revealed that urea synthesis from differentiated hepatocytelike cells in scaffold was 1.4 ± 0.6 pg/cell/h in the fi rst week of differentiation, but was not detected in the control group at the same time. In the next 2 weeks, the urea concentration increased to 10.1 ± 3.5 pg/cell/h and 24.6 ± 3.0 pg/cell/h in scaffold group. At the same observation period, urea concentration was only 4.9 ± 1.6 pg/cell/h and 11.7 ± 3.8 pg/ cell/h, respectively, in the control group. The capability to synthesize urea in differentiated hepatocyte-like cells in C-PLGA scaffold was signifi cantly higher than that in the monolayer differentiation system ( P < 0.05). Metabolism analysis of ammonia and diazepam ( Fig. 6C and 6D ) showed similar results in C-PLGA scaffold group and monolayer differentiation group. In the fi rst week of differentiation in the monolayer culture system to the 3D culture system. In contrast, the percentage of differentiated cells in monolayer culture system decreased gradually (cell confl uence before and 0.86 ± 0.11 pg/cell/h vs. 0.48 ± 0.08 pg/cell/h in the third week) compared to the monolayer control group during the same observation period. The results suggest that the metabolic function-including ALB secretion, urea synthesis, ammonia elimination, and diazepam clearance-from differentiated hepatocyte-like cells in C-PLGA scaffolds was signifi cantly higher than that in the control ( P < 0.05).
Histochemical and PAS staining
The result of H&E staining ( Fig. 7 ) showed that differentiated BMSCs formed grape-shaped small cell clusters and the cells' morphology was changed from spindly to round shape in the second week of differentiation in C-PLGA scaffolds. A liver-like tissue was formed in the third week of differentiation. The result of PSA staining showed that glycogen was positive (cytoplasm stains pink) in the fi rst week of differentiation. After 2 weeks of differentiation, the glycogen was expressed increasingly. The signifi cantly increased expression of glycogen from differentiated BMSCderived hepatocyte-like cells confi rms the supporting roles of C-PLGA scaffolds.
Discussion
Since the fi rst demonstration of bone marrow stem cells differentiation into hepatocytes by Petersen et al. [ 32 ] , the hepatogenic differentiation from BMSCs has been confi rmed widely [32] [33] [34] [35] . This fi nding raised the possibility that these cells could be used for treatment of end-stage liver diseases due to various etiologies [ 36 ] . However, subsequent studies indicated that frequency of the transdifferentiation scaffolds, the capability to eliminate ammonia and clear diazepam was 0.08 ± 0.02 pg/cell/h and 0.08 ± 0.05 pg/cell/h, respectively, but neither was not detected at all in the control group. Ammonia elimination increased >2-fold (0.32 ± 0.06 pg/cell/h vs. 0.11 ± 0.02 pg/cell/h at week 2 and 1.19 ± 0.21 pg/cell/h vs. 0.42 ± 0.1 pg/cell/h at week 3) in the scaffold differentiation system compared to the control during the next 2-week observation period. Diazepam clearance in the scaffold group indicated the same increased trend (0.52 ± 0.08 pg/cell/h vs. 0.34 ± 0.03 pg/cell/h in the second week viability and proliferation, as indicated by previous reports [ 13 , 18 , 21 , 48 ] . In addition, many hepatocyte-specifi c genes commonly used to characterize the profi ling of stem cell-derived hepatocyte-like cells (such as ALB, AFP, CK18, CK19, G6PD, and HNF-4) were expressed in our C-PLGA scaffold group 1 week earlier than that in our control group. Western blot analysis confi rmed a similar result, namely that differentiated hepatocyte-like cells expressed liver-enriched functional markers including ALB, P450, CK18, and CK19 earlier by 1 week in scaffold group than that in control. These results demonstrated an effective differentiation of hepatocyte-like cells in scaffolds. Furthermore, biochemical analysis ( Fig. 6 ) validated that BMSC-derived hepatocyte-like cells expressed hepatic metabolic functions (ALB secretion, urea synthesis, ammonia elimination, and diazepam clearance) higher ( P < 0.05) and earlier by 1 week in C-PLGA scaffold compared with control. The results of histochemistry revealed that differentiated BMSCs in scaffolds exhibit hepatocyte morphology and form liver-like tissue in the third week after differentiation. Glycogen was expressed increasingly from differentiated BMSCs in scaffolds during the period of 3-week differentiation. These results confi rmed our previous knowledge that 3D scaffold architecture provides a fi ne microenvironment to support differentiation of BMSCs.
In summary, BMSC-derived hepatocyte-like cells on C-PLGA scaffold expressed hepatocyte-specifi c genes and markers (ALB, AFP, CK18, CK19, G6PD, HNF-4α, P450, and collagen)-at mRNA and protein levels-1 week earlier by than those in a monolayer culture system. Successful transdifferentiation rates of BMSCs to mature hepatocytes with signifi cantly higher metabolic functions on C-PLGA scaffold as compared to the monolayer culture system demonstrated the superiority of the scaffold. Although many additional issues need to be addressed in future studies, based on the above analysis and characterization, our experiments indicate that engineered 3D C-PLGA scaffolds can provide a suitable phenomenon and survival of implanted cells in vivo is very low [ 37 , 38 ] . Liver tissue engineering based on synthetic scaffolds provides a promising alternative to hepatocyte infusion into the portal vein or injection into the splenic pulp for treatment of end-stage hepatic failure [ 39 , 40 ] . As an important part of liver tissue engineering, scaffolds provide a place for cell attachment, increased surface area, and support for a large cell mass and specifi c structures [41] [42] [43] . More importantly, the scaffold must be biocompatible, allowing the organ to grow inside and support itself over time. Our previous work [ 28 ] showed that a collagen-modifi ed 3D PLGA scaffold was superior to a control without collagen modification and to a 2D culture system in supporting growth and metabolism of primary human hepatocytes. The cell number and lifespan of primary hepatocytes were signifi cantly greater in collagen-coated PLGA scaffolds compared with those in a control PLGA scaffold without collagen modification. The capability of cultured hepatocytes to synthesize ALB and urea, and metabolize ammonia and diazepam in C-PLGA scaffold was signifi cantly higher than that in control. Although different synthetic scaffolds have been fabricated and used for liver tissue engineering [44] [45] [46] [47] , reports on the transdifferentiation of BMSCs into the hepatic lineage in a C-PLGA scaffold are infrequent. This work was motivated by the hypothesis that C-PLGA scaffolds can provide a good microenvironment for differentiation of BMSCs into hepatocyte-like cells in vitro.
As described in the methods section, following phenotype profi ling of freshly isolated BMSCs derived from rat bone marrow, BMSCs were seeded into collagen-coated PLGA scaffolds. The phenotypic feature analysis demonstrated that BMSCs were positive for CD29 and CD90, but negative for CD45 and β 2 m. Previous reports showed that biomodifi ed 3D scaffolds infl uenced cell behaviors. Our results on cells survival and scaffold biocompatibility revealed that the biomodifi ed 3D structure could provide the hepatocytelike cells with an excellent environment, supportive of cell was observed in the third week of differentiation. PSA staining showed that glycogen was positive (cytoplasm stains pink, short solid arrow) in the fi rst week. After 2 weeks of differentiation, the glycogen was expressed increasingly. ( A and E , before differentiation; B and F , the fi rst week of differentiation; C and G , the second week of differentiation; D and H , the third week of differentiation) (original magnifi cation: A and E , 10×; B , D , and F-H , 20×; C, 40×).
